Related Experiment Video
Updated: May 25, 2026

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
Published on: November 22, 2024
Reversed chloroquine molecules as a strategy to overcome resistance in malaria
1Department of Chemistry, Portland State University, Portland, OR 97207-0751, USA. peytond@pdx.edu
Abstract:
This short review tells the story of how Reversed Chloroquine drugs (RCQs) were developed. These are hybrid molecules, made by combining the quinoline nucleus from chloroquine (CQ) with moieties which are designed to inhibit efflux via known transporters in the membrane of the digestive vacuole of the malaria parasite. The resulting RCQ drugs can have potencies exceeding that of CQ, while at the same time having physical chemical characteristics that may make them favorable as partner drugs in combination therapies. The need for such novel antimalarial drugs will continue for the foreseeable future.
Related Concept Videos
Anthelminthic Agents
Treatment Resistant Cancers
Diversity of Protists II
Retrovirus Life Cycles
Microbial Bioremediation of Pesticides

